NatureWise Biotech & Medicals Corporation
4732
Rank in Stocks
#26122
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily... NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.
Share Price
$0.45421844
Last synced: 2026-11-10
Market Cap
$22.01M
Change (1 day)
0.00%
Change (1 year)
-28.72%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NatureWise Biotech & Medicals Corporation (4732)
Category
Healthcare
EPS for NatureWise Biotech & Medicals Corporation (4732)
EPS as of June 2026 TTM: $-0.09
According to NatureWise Biotech & Medicals Corporation's latest financial reports, its current EPS (TTM) is $-0.09. At the end of 2025 the company had an EPS of $-0.06, a decrease compared to its 2024 EPS of 0.00.
EPS history for NatureWise Biotech & Medicals Corporation from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.09 | 42.00% |
| 2025 | $-0.06 | -12,140.00% |
| 2024 | 0.00 | -92.31% |
| 2023 | $0.01 | -67.34% |
| 2022 | $0.02 | -11.16% |
| 2021 | $0.02 | -52.34% |
| 2020 | $0.05 | 33.90% |
| 2019 | $0.04 | -367.94% |
| 2018 | $-0.01 | -76.18% |
| 2017 | $-0.06 | 10.22% |
| 2016 | $-0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -18,480.28% |
US
|
|
| $-7.07 | 8,198.12% |
US
|
|
| $-5.29 | 6,108.92% |
AU
|
|
| $12.88 | -15,217.49% |
BE
|
|
| $21.56 | -25,405.16% |
NL
|
Questions about NatureWise Biotech & Medicals Corporation's earnings per share (EPS)
What is NatureWise Biotech & Medicals Corporation's earnings per share (EPS)?
NatureWise Biotech & Medicals Corporation's earnings per share (EPS) over the last twelve months is $-0.09, as of Jun 2026.
What was NatureWise Biotech & Medicals Corporation's earnings per share (EPS) in 2025?
In 2025, NatureWise Biotech & Medicals Corporation's earnings per share (EPS) was $-0.06, compared with 0.00 in 2024.
How has NatureWise Biotech & Medicals Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, NatureWise Biotech & Medicals Corporation's earnings per share (EPS) was highest in 2020 ($0.05) and lowest in 2025 ($-0.06).
How does NatureWise Biotech & Medicals Corporation's earnings per share (EPS) compare with similar companies?
NatureWise Biotech & Medicals Corporation's earnings per share (EPS) ($-0.09) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.